Friedman Daniel J, Al-Khatib Sana M
Duke Clinical Research Institute, PO Box 17969, Durham, NC, 27715, USA.
J Interv Card Electrophysiol. 2016 Oct;47(1):5-10. doi: 10.1007/s10840-016-0118-5. Epub 2016 Mar 3.
The evolving healthcare environment demands optimally measured quality of care. Performance measures are increasingly being used for quality improvement, public reporting, and reimbursement determinations. The National Quality Forum has created rigorous criteria for the evaluation of potential performance measures across medical fields. The Heart Rhythm Society has championed the development of four separate electrophysiology (EP)-specific performance measures: implantable cardioverter defibrillator complication rate, cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation, infection within 180 days of a cardiac implantable electronic device implantation, replacement, or revision, and in-person evaluation following a cardiac implantable electronic device implantation. National registries serve a key role in developing performance measures and facilitating quality improvement, particularly as they provide improved granularity and accuracy of data compared with administrative claims data. All performance measures demand continued reassessment as technology and performance gaps change and as unintended consequences may arise.
不断演变的医疗环境要求对医疗质量进行最佳衡量。性能指标越来越多地用于质量改进、公开报告和报销确定。国家质量论坛已经制定了严格的标准,用于评估各个医学领域潜在的性能指标。心律协会倡导制定四项独立的特定于电生理学(EP)的性能指标:植入式心脏复律除颤器并发症发生率、心房颤动消融术后心包填塞和/或心包穿刺术、心脏植入式电子设备植入、更换或翻修后180天内的感染,以及心脏植入式电子设备植入后的亲自评估。国家登记处对于制定性能指标和促进质量改进起着关键作用,特别是与行政索赔数据相比,它们能提供更详细和准确的数据。随着技术和性能差距的变化以及可能出现意外后果,所有性能指标都需要持续重新评估。